198 related articles for article (PubMed ID: 9469587)
1. Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts.
Verhoeven NM; Roe DS; Kok RM; Wanders RJ; Jakobs C; Roe CR
J Lipid Res; 1998 Jan; 39(1):66-74. PubMed ID: 9469587
[TBL] [Abstract][Full Text] [Related]
2. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
3. Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.
Singh H; Beckman K; Poulos A
J Biol Chem; 1994 Apr; 269(13):9514-20. PubMed ID: 8144536
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid beta-oxidation in peroxisomes and mitochondria: the first, unequivocal evidence for the involvement of carnitine in shuttling propionyl-CoA from peroxisomes to mitochondria.
Jakobs BS; Wanders RJ
Biochem Biophys Res Commun; 1995 Aug; 213(3):1035-41. PubMed ID: 7654220
[TBL] [Abstract][Full Text] [Related]
5. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz.
Singh I; Pahan K; Dhaunsi GS; Lazo O; Ozand P
J Biol Chem; 1993 May; 268(14):9972-9. PubMed ID: 8486724
[TBL] [Abstract][Full Text] [Related]
6. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
[TBL] [Abstract][Full Text] [Related]
7. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
Singh I; Pahan K; Singh AK; Barbosa E
J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
[TBL] [Abstract][Full Text] [Related]
8. Peroxisomal beta-oxidation of branched chain fatty acids in human skin fibroblasts.
Singh H; Brogan M; Johnson D; Poulos A
J Lipid Res; 1992 Nov; 33(11):1597-605. PubMed ID: 1464743
[TBL] [Abstract][Full Text] [Related]
9. Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
Kase BF; Björkhem I
Scand J Clin Lab Invest; 1996 May; 56(3):211-7. PubMed ID: 8761525
[TBL] [Abstract][Full Text] [Related]
10. Human metabolism of phytanic acid and pristanic acid.
Verhoeven NM; Jakobs C
Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
[TBL] [Abstract][Full Text] [Related]
11. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
[TBL] [Abstract][Full Text] [Related]
12. Impaired peroxisomal fatty acid oxidation in human skin fibroblasts with a mitochondrial acylcarnitine/carnitine translocase deficiency.
Jakobs BS; Wanders RJ
J Inherit Metab Dis; 1996; 19(2):185-7. PubMed ID: 8739961
[No Abstract] [Full Text] [Related]
13. The metabolism of phytanic acid and pristanic acid in man: a review.
Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
[TBL] [Abstract][Full Text] [Related]
14. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.
Chalmers RA; Stanley CA; English N; Wigglesworth JS
J Pediatr; 1997 Aug; 131(2):220-5. PubMed ID: 9290607
[TBL] [Abstract][Full Text] [Related]
16. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
17. Carnitine--metabolism and functions.
Bremer J
Physiol Rev; 1983 Oct; 63(4):1420-80. PubMed ID: 6361812
[TBL] [Abstract][Full Text] [Related]
18. Peroxisomal fatty acid oxidation and inhibitors of the mitochondrial carnitine palmitoyltransferase I in isolated rat hepatocytes.
Skorin C; Necochea C; Johow V; Soto U; Grau AM; Bremer J; Leighton F
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):561-7. PubMed ID: 1736904
[TBL] [Abstract][Full Text] [Related]
19. A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids.
Christensen E; Pedersen SA; Leth H; Jakobs C; Schutgens RB; Wanders RJ
J Inherit Metab Dis; 1997 Sep; 20(5):658-64. PubMed ID: 9323560
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and expression of human carnitine octanoyltransferase: evidence for its role in the peroxisomal beta-oxidation of branched-chain fatty acids.
Ferdinandusse S; Mulders J; IJlst L; Denis S; Dacremont G; Waterham HR; Wanders RJ
Biochem Biophys Res Commun; 1999 Sep; 263(1):213-8. PubMed ID: 10486279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
